RAD.AX - Radiopharm Theranostics Limited

ASX - ASX Delayed price. Currency in AUD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2022
Total revenue
-
8.831
Gross profit
-
8.831
Operating expenses
Research development
10,823
4,125
Selling general and administrative
12,167
12,439
Total operating expenses
28,224
20,954
Operating income or loss
-27,923
-20,945
Interest expense
1,331
9,350
Total other income/expenses net
3,557
-1,028
Income before tax
-25,415
-30,295
Income tax expense
85.441
44.397
Income from continuing operations
-25,500
-30,339
Net income
-25,500
-30,339
Net income available to common shareholders
-25,500
-30,339
Basic EPS
-
-0.16
Diluted EPS
-
-0.16
Basic average shares
-
187,490
Diluted average shares
-
187,490
EBITDA
-
-20,945